Rainbow Childrens Medicare Ltd
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
- Market Cap ₹ 13,761 Cr.
- Current Price ₹ 1,355
- High / Low ₹ 1,646 / 1,009
- Stock P/E 49.2
- Book Value ₹ 162
- Dividend Yield 0.22 %
- ROCE 18.2 %
- ROE 17.9 %
- Face Value ₹ 10.0
Pros
- Company's median sales growth is 22.8% of last 10 years
Cons
- Stock is trading at 8.35 times its book value
- Working capital days have increased from 52.8 days to 95.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE 250 SmallCap Index BSE 400 MidSmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 | 234 | 321 | 402 | 543 | 719 | 650 | 974 | 1,174 | 1,297 | 1,516 | 1,703 | |
| 128 | 204 | 266 | 332 | 391 | 519 | 485 | 666 | 774 | 865 | 1,022 | 1,159 | |
| Operating Profit | 41 | 30 | 55 | 69 | 151 | 201 | 165 | 308 | 400 | 432 | 494 | 544 |
| OPM % | 24% | 13% | 17% | 17% | 28% | 28% | 25% | 32% | 34% | 33% | 33% | 32% |
| 10 | 16 | 11 | 10 | 8 | 10 | 10 | 19 | 31 | 37 | 51 | 42 | |
| Interest | 3 | 3 | 3 | 4 | 42 | 48 | 46 | 56 | 58 | 63 | 77 | 78 |
| Depreciation | 9 | 18 | 22 | 28 | 60 | 69 | 73 | 83 | 90 | 112 | 138 | 151 |
| Profit before tax | 38 | 24 | 41 | 47 | 58 | 93 | 56 | 187 | 282 | 295 | 330 | 358 |
| Tax % | 35% | 28% | 24% | 22% | 22% | 41% | 29% | 26% | 25% | 26% | 26% | 21% |
| 25 | 17 | 31 | 36 | 45 | 55 | 40 | 139 | 212 | 218 | 244 | 282 | |
| EPS in Rs | 26.74 | 18.22 | 33.78 | 8.25 | 10.14 | 12.68 | 9.10 | 14.70 | 20.77 | 21.38 | 23.97 | 27.40 |
| Dividend Payout % | 7% | 11% | 7% | 12% | 10% | 16% | 0% | 14% | 14% | 14% | 13% | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 13% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 48% |
| 3 Years: | 10% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 18% |
| Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 | 102 | 102 |
| Reserves | 166 | 275 | 308 | 307 | 317 | 350 | 391 | 498 | 958 | 1,157 | 1,367 | 1,547 |
| 22 | 24 | 26 | 24 | 476 | 501 | 529 | 592 | 570 | 765 | 764 | 891 | |
| 34 | 41 | 55 | 73 | 89 | 123 | 116 | 112 | 146 | 146 | 145 | 236 | |
| Total Liabilities | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,776 | 2,170 | 2,377 | 2,775 |
| 78 | 123 | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1,253 | 1,398 | 1,759 | |
| CWIP | 35 | 31 | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 28 | 76 |
| Investments | 7 | 2 | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 | 404 |
| 111 | 194 | 212 | 140 | 199 | 265 | 262 | 409 | 764 | 590 | 380 | 535 | |
| Total Assets | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,776 | 2,170 | 2,377 | 2,775 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 17 | 36 | 48 | 127 | 170 | 143 | 224 | 327 | 321 | 396 | 420 | |
| -20 | -107 | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -226 | -268 | -259 | |
| -7 | 93 | -1 | -7 | -9 | -52 | -61 | -44 | 143 | -102 | -118 | -147 | |
| Net Cash Flow | -1 | 3 | 1 | -2 | 2 | 2 | -1 | 4 | 5 | -7 | 10 | 14 |
| Free Cash Flow | -35 | -46 | -21 | -103 | 42 | 96 | 67 | 162 | 186 | -32 | 250 | 204 |
| CFO/OP | 95% | 88% | 79% | 88% | 94% | 95% | 102% | 93% | 102% | 95% | 97% | 96% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 10 | 16 | 14 | 24 | 22 | 25 | 15 | 18 | 20 | 19 | 22 |
| Inventory Days | 39 | 35 | 48 | 36 | 32 | 55 | 36 | 28 | 43 | 53 | 52 | 67 |
| Days Payable | 121 | 107 | 142 | 151 | 197 | 202 | 190 | 121 | 195 | 180 | 170 | 162 |
| Cash Conversion Cycle | -72 | -62 | -79 | -100 | -141 | -124 | -130 | -78 | -133 | -107 | -100 | -73 |
| Working Capital Days | -35 | -36 | -28 | -31 | -26 | -18 | -17 | -16 | 73 | 44 | 19 | 95 |
| ROCE % | 22% | 11% | 14% | 14% | 16% | 16% | 11% | 23% | 24% | 19% | 19% | 18% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|
| Bed Capacity (Total) Number |
|
||||||
| ALOS (Average Length of Stay) Days |
|||||||
| ARPOB (Average Revenue Per Occupied Bed) INR/Day |
|||||||
| Inpatient Discharges Number |
|||||||
| Number of Deliveries Number |
|||||||
| Occupancy Percentage |
|||||||
| Operational Beds Number |
|||||||
| Outpatient Consultations Number |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
5h - FY26 audited results approved; final dividend ₹3.5/share, AGM on July 29, 2026, record date July 21.
-
Announcement under Regulation 30 (LODR)-Change in Management
6h - Board approved FY26 audited results, Rs 3.5 dividend, July 29 AGM, and reappointments.
-
Announcement under Regulation 30 (LODR)-Change in Management
5h - Board approved FY26 audited results, ₹3.5 final dividend, July 29 AGM, and director reappointments.
-
Announcement under Regulation 30 (LODR)-Change in Management
5h - Board approved FY26 audited results, ₹3.5 final dividend, AGM on July 29, 2026, record date July 21.
-
Announcement under Regulation 30 (LODR)-Change in Management
5h - Board approved FY26 audited results, ₹3.5 final dividend, July 29 AGM, July 21 record date, and reappointments.
Annual reports
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022Transcript PPT
Business Overview[1]
The company operates 22 hospitals and 5 clinics across 9 cities, with a total bed capacity of 2,285. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."